These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


538 related items for PubMed ID: 30665674

  • 1. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ, Mohammed S, Curnow J, Pasalic L.
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
    Reda S, Brügelmann A, Müller J, Oldenburg J, Pötzsch B, Rühl H.
    Sci Rep; 2020 Jul 22; 10(1):12221. PubMed ID: 32699227
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.
    Slavik L, Jacova J, Friedecky D, Ulehlova J, Tauber Z, Prochazkova J, Hlusi A, Palova M.
    Clin Appl Thromb Hemost; 2019 Jul 22; 25():1076029619872556. PubMed ID: 31523979
    [Abstract] [Full Text] [Related]

  • 10. Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant.
    Novelli C, Pradella P, Papandrea M, Montaruli B.
    Blood Coagul Fibrinolysis; 2023 Apr 01; 34(3):199-205. PubMed ID: 37017015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants.
    Favaloro EJ.
    Clin Chem Lab Med; 2019 May 27; 57(6):873-882. PubMed ID: 30485173
    [Abstract] [Full Text] [Related]

  • 15. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
    Jourdi G, Delrue M, Stepanian A, Valaize J, Foulon-Pinto G, Demagny J, Duchemin J, Nedelec-Gac F, Darnige L, Curis E, Delavenne X, Gaussem P, Siguret V, Gouin-Thibault I.
    Thromb Res; 2019 Dec 27; 184():86-91. PubMed ID: 31710863
    [Abstract] [Full Text] [Related]

  • 16. Screening test for direct oral anticoagulants with the dilute Russell viper venom time.
    Pratt J, Crispin P.
    Eur J Haematol; 2018 Jun 27; 100(6):567-574. PubMed ID: 29486103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.
    Bonar R, Favaloro EJ, Mohammed S, Ahuja M, Pasalic L, Sioufi J, Marsden K.
    Pathology; 2016 Jan 27; 48(1):60-71. PubMed ID: 27020211
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants.
    Flieder T, Weiser M, Eller T, Dittrich M, von Bargen K, Alban S, Kuhn J, Knabbe C, Birschmann I.
    Thromb Res; 2018 May 27; 165():101-106. PubMed ID: 29627719
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.